These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5923334)

  • 1. Protective effect of specific immunization in Rauscher leukemia.
    Barski G; Youn JK
    Natl Cancer Inst Monogr; 1966 Sep; 22():659-69. PubMed ID: 5923334
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of the modifying effect of neuraminidase of the influenza virus on the development of Rauscher leukemia].
    Novichenko NL; Struk VI
    Eksp Onkol; 1984; 6(3):29-32. PubMed ID: 6499739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodepressive effect of Rauscher leukemia virus on antinuclear antibody formation in New Zealand black mice.
    Siegel BV; Brown M; Morton JI
    J Natl Cancer Inst; 1972 Jan; 48(1):159-63. PubMed ID: 4568962
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1967 Oct; 27(10):1743-8. PubMed ID: 6064953
    [No Abstract]   [Full Text] [Related]  

  • 5. Further studies on mouse fetal antigen cross-reactive with Rauscher leukemia.
    Ishimoto A; Suzuki Y; Yoshida T; Ito Y
    Cancer Res; 1974 Sep; 34(9):2338-43. PubMed ID: 4846102
    [No Abstract]   [Full Text] [Related]  

  • 6. [Group and type specific antigens of Rauscher viral leukemia].
    Engel'gardt NV; Abelev GI; Ievleva ES
    Vopr Onkol; 1969; 15(10):76-84. PubMed ID: 4984573
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of 7S- and 19S-antibodies in the mechanism of stimulation and inhibition of Rauscher virus leukemia in mice].
    Ter-Grigorov VS; Shevelev BI; Moskovkina OIa; Bergol'ts VM
    Biull Eksp Biol Med; 1971 Jan; 71(1):61-4. PubMed ID: 5552664
    [No Abstract]   [Full Text] [Related]  

  • 8. [Decline of the malignancy of a cell strain in mice follwoing chronic infection in vitro by the Rauscher leukemia virus].
    Barbieri D; Barski G
    Rev Fr Etud Clin Biol; 1968; 13(7):703-6. PubMed ID: 5726635
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of cellular and humoral immunity in mice infected with Rauscher leukemia virus following administration of serum against isologous aggregated immunoglobulins].
    Snegireva AE; Khorobrykh VV; Kaulen DR; Merimskaia OS; Shevliagin VIa
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (7):27-33. PubMed ID: 6967739
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of resistance against the transplantation of leukemias induced by Rauscher virus.
    Bianco AR; Glynn JP; Goldin A
    Cancer Res; 1966 Aug; 26(8):1722-8. PubMed ID: 5923170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunogenetic control over the spontaneous regression of Rauscher leukemia in mice].
    Klepikov NN
    Dokl Akad Nauk SSSR; 1980; 255(1):250-2. PubMed ID: 7460751
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison by several techniques of the antibody prepared in various species against the Rauscher murine leukemia virus.
    Fink MA; Cowles CA; Chirigos MA; Messore J
    Natl Cancer Inst Monogr; 1966 Sep; 22():439-47. PubMed ID: 4958836
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possible mechanism of the resistance of C57Bl/6 mice to a mixed infection with Mycoplasma arthritidis and Rauscher leukemia virus].
    Sanin AV; Rakovskaia IV; Khorobrykh VV
    Mikrobiol Zh (1978); 1981; 43(2):199-202. PubMed ID: 7231223
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitation and ultrastructure of immunodepression in murine virus-induced leukemia.
    Siegel BV; Neher GH; Morton JI
    Lab Invest; 1969 Apr; 20(4):347-52. PubMed ID: 5776328
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rauscher virus and Rauscher disease. 3. Multiplication of Rauscher virus in cultured spleen cells].
    Miyoshi I; Osato S; Irino S; Hiraki K
    Igaku To Seibutsugaku; 1966 Jun; 72(6):316-20. PubMed ID: 6005890
    [No Abstract]   [Full Text] [Related]  

  • 16. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of splenocytes, associated with temporal exposition of D-galactosyl residues, in Rauscher leukemia.
    Novichenko NL
    Arch Geschwulstforsch; 1984; 54(4):279-84. PubMed ID: 6497576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of sublines of a mouse leukemia virus with murine antibody, as measured by the spleen focus assay.
    Sinkovics JG; Pienta RJ; Fiorentino M; Bertin BA
    Cancer Res; 1967 Jan; 27(1):88-94. PubMed ID: 6020368
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rauscher virus and Rauscher disease. 2. Histopathological and histochemical study of Rauscher disease].
    Irino S; Osato S; Mimura H; Dabasaki H; Hiraki K
    Igaku To Seibutsugaku; 1966 Jun; 72(6):310-5. PubMed ID: 6005889
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rauscher virus and Rauscher disease. 4. Histopathological study of Rauscher disease in AKR mice with special reference to characteristic lesions of the kidney].
    Miyoshi I; Osat Y; Irino S; Hiraki K
    Igaku To Seibutsugaku; 1966 Jul; 73(1):1-4. PubMed ID: 6007796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.